Director's Dealing • Dec 6, 2016
Director's Dealing
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information
RNS Number : 0816R
Oxford Biomedica PLC
06 December 2016
Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons
| 1 | Issuer | Oxford BioMedica PLC |
| 2 | Reason for notification | Notification relates to DTR 3.1.2R |
| 3 | Name of PDMR | Martin Diggle |
| 4 | Connected person | Notification relates to following connected persons: Vulpes Life Sciences Fund |
| 5 | Notification in respect of | Notification in respect of holdings of persons in 4 above |
| 6 | Description of shares | Oxford BioMedica PLC ordinary shares of 1p each |
| 7 | Name of registered shareholders and number of shares | Vulpes Life Sciences Fund - 575,850,000 shares |
| 8 | Nature of transaction | Acquisition |
| 9 | Number of shares acquired | Vulpes Life Sciences Fund - 833,000 shares |
| 10 | Percentage of issued class acquired | Vulpes Life Sciences Fund - 0.03% |
| 11 | Shares disposed | N/A |
| 12 | Percentage of issued class disposed | N/A |
| 13/14 | Price per share of transactions, and date | Vulpes Life Sciences Fund 833,000 shares @ £0.0355 , 05 Dec 2016 |
| 15 | Total holding following notification and total percentage holding following notification | Vulpes Life Sciences Fund - 547,432,000 shares 17.73% Vulpes Testudo Fund - 33,333,333 shares 1.08% |
| 16 | Date issuer informed | 06 Dec 2016 |
| 23 | Any additional information | None |
| 24 | Contact name and telephone number | T. Watts, Chief Financial Officer Oxford BioMedica +44 (0)1865 783000 |
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHGCBDDSBGBGLL
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.